1. Enhancement of mucosal defense by prostaglandins. Rationale and clinical experience in ulcer disease;Rask-Madsen, J.; Lauritsen, K.;Scand3t Gastroenterol,1987
2. Enprostil and ranitidine in duodenal ulcer healing: double-blind comparative trial;Lauritsen, K.; Laursen, L.S.; Havelund, T.; Bytzer, P.; Svendsen, L.B.; Rask-Madsen, J.,1986
3. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70, ug compared with ranitidine 300 mg in duodenal ulcer;Walt, R.P.; Pounder, R.E.; Hawkey, C.J.; Sontana, I.A.; Somerville, K.W.; Logan, R.F.;Aliment Pharmacol Ther,1987
4. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial;Lauritsen, K.; Havelund, T.; Laursen, L.S.; Bytzer, P.; Kjxrgaard, J.; Rask-Madsen, J.;BMJ,1987
5. Prostaglandins for peptic ulcer: a promise unfulfilled;Hawkey, C.J.; Walt, R.P.;Lancet,1986